Retatrutide 30mg

Retatrutide 30mg is a research-grade synthetic peptide supplied as a single lyophilized vial for in-vitro and laboratory research only. It is studied as a triple receptor agonist, meaning a single molecule that interacts with three receptor types: GIP, GLP-1, and glucagon. GIP stands for glucose-dependent insulinotropic polypeptide. GLP-1 stands for glucagon-like peptide-1. These are incretins, signaling molecules involved in metabolic pathways.

The compound is also known by its development code, LY3437943. It is an investigational compound, which means it is still under scientific study and is not an approved product. Each vial contains 30mg of lyophilized peptide for laboratory reconstitution.

This product is furnished strictly for in-vitro laboratory research. It is not for human consumption. It is not approved by the FDA or EMA to prevent, treat, or cure any condition. Introduction into humans or animals is prohibited by law.

Retatrutide is studied as a triple receptor agonist. A receptor agonist is a molecule that binds to a receptor and activates it. In this case, a single peptide activates three receptors at the same time: GIP, GLP-1, and glucagon. These belong to a family called class B G protein-coupled receptors, a group of receptors involved in signaling.

This triple activity is the main focus of research interest. It distinguishes the compound from peptides that act on one receptor (GLP-1 only) or two receptors (GIP and GLP-1). Researchers use it to study how combined receptor activation behaves in controlled laboratory models.

Common research areas include receptor binding, signaling pathways, and metabolic signaling. Binding refers to how the molecule attaches to its target receptor. Signaling refers to the chain of events triggered inside the cell after binding.

Its distinct structure also makes it a useful point of comparison in receptor pharmacology studies. All findings come from controlled laboratory environments. This product is not for use in humans or animals.

Retatrutide is supplied as a 30mg lyophilized powder. Lyophilized means freeze-dried for stability. Handling should follow sterile laboratory technique by qualified personnel only.

Before reconstitution, store the vial at −20°C for long-term stability. Keep the vial sealed and protected from moisture and light until use. Consistent storage conditions help preserve molecular stability.

Reconstitution means dissolving the powder in a sterile laboratory solution, typically bacteriostatic or sterile water for peptides of this class. Confirm the correct solvent, volume, and concentration in the lot-specific documentation and Certificate of Analysis before use. After reconstitution, refrigerate the solution and use it within a validated timeframe.

Label prepared samples clearly with the compound name, concentration, solvent, lot number, and preparation date. Dispose of unused material according to institutional laboratory waste protocols. This product is supplied in a research vial format only and is labeled For Research Use Only.

Each batch undergoes purity verification to confirm research-grade quality. Testing is performed by HPLC analysis. HPLC stands for high-performance liquid chromatography, a standard method for measuring compound purity.

A Certificate of Analysis accompanies each order. This document records the purity results and confirms the compound identity. Always confirm purity and specifications using the lot-specific documentation rather than visual inspection.

Testing also verifies molecular weight and compound identity. Molecular weight is the measured mass of the peptide. These checks confirm the vial contains the expected compound.

Batch-to-batch consistency supports reliable results across research protocols. This documentation supports accurate research records and institutional compliance.

• CAS: 2381089-83-2
• Chemical Formula: C₂₂₁H₃₄₂N₄₆O₆₈
• Molecular Weight: 4845.444 g/mol
• Peptide Sequence: Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 (Sodium salt)
• Synonyms: Retatrutide acetate, LY3437943

Retatrutide is a synthetic peptide, meaning it is made in a lab rather than extracted from a natural source. Synthetic production supports batch-to-batch consistency for research use.

It is a single molecule that activates three class B G protein-coupled receptors. This triple-receptor structure is what distinguishes it from single-receptor and dual-receptor peptides. Its development code is LY3437943.

The compound is supplied as a lyophilized powder. In this form, the peptide is stable and suitable for storage before use. It is reconstituted in a sterile solution for laboratory study.

Researchers study these structural and chemical characteristics under standardized protocols. This product is supplied strictly for in-vitro research. It is not for human consumption.

Retatrutide 30mg is a research-grade synthetic peptide supplied as a single lyophilized vial. It is studied as a triple receptor agonist, meaning one molecule that interacts with three receptor types: GIP, GLP-1, and glucagon. It is an investigational compound, supplied strictly for in-vitro laboratory research. It is not for human consumption.

It is supplied as one vial containing 30mg of lyophilized (freeze-dried) powder. The powder is reconstituted in a sterile laboratory solution before use. Each order is accompanied by a Certificate of Analysis confirming compound identity and purity by HPLC.

Before reconstitution, store the sealed vial at −20°C, protected from moisture and light. After reconstitution, refrigerate the solution and use it within a validated timeframe. Confirm lot-specific storage details in the Certificate of Analysis.

Its defining feature is triple-receptor activity. This distinguishes it from peptides that act on one receptor (GLP-1 only) or two receptors (GIP and GLP-1). This profile makes it a useful point of comparison in receptor pharmacology and signaling studies.

This compound is supplied only to qualified researchers and institutions operating within approved research frameworks. It is furnished strictly for laboratory research use only and is not available by prescription.